
Cogent Biosciences, Inc.
Cogent Biosciences, Inc. (COGT)
WebsitePrice
Market cap
Next catalystNov 30, 2026Bezuclastinib plus sunitinib — GIST indication overview · Regulatory decisionCompany release ↗
Cash
Chart & Events
Core Clinical
BezuclastinibBezuclastinib plus sunitinib — GIST indication overview
Small molecule
mutant KIT, including KIT D816V
Technology Summary
Scientific context
Detailed technology interpretation
Technology advantages
Clinical
Upcoming clinical milestones
BezuclastinibBezuclastinib plus sunitinib — GIST indication overview
Small molecule
mutant KIT, including KIT D816V